Number of shares and voting rights, as of January 31, 2007
Operating revenue of 8.4 million euros in 2006
Operating revenue of 8.4 million euros in 2006
Key millestone achieved by Innate Pharma's partner, Clinical Data, Inc.
Financial calendar for 2007
Innate Pharma announces worldwide exclusive license with Clinical Data Inc.
Innate Pharma announces the full exercise of the greenshoe in the context of its initial public offering (IPO) on the Eurolist market (Compartment C) of Euronext Paris
Innate Pharma announces the success of its initial public offering (IPO) on the Eurolist market (Compartment C) of Euronext Paris
Innate Pharma SA announces the details of its initial public offering on the Eurolist market at Euronext Paris
Launch of Innate Pharma's IPO on Eurolist C by Euronext in Paris
